Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predicted broadly neutralizing antibody (bnAb) resistance and associated envelope characteristics of adults with HIV-1 seroconversion in Botswana.
Moraka NO, Choga WT, Pema MN, Chawawa MK, Gobe I, Mokomane M, Bareng OT, Bhebhe L, Kelentse N, Mulenga G, Pretorius-Holme M, Mohammed T, Koofhethile CK, Makhema JM, Shapiro R, Lockman S, Moyo S, Gaseitsiwe S. Moraka NO, et al. Among authors: pema mn. Res Sq [Preprint]. 2023 Aug 29:rs.3.rs-3194948. doi: 10.21203/rs.3.rs-3194948/v1. Res Sq. 2023. Update in: Sci Rep. 2023 Oct 24;13(1):18134. doi: 10.1038/s41598-023-44722-2 PMID: 37693564 Free PMC article. Updated. Preprint.
Predicted resistance to broadly neutralizing antibodies (bnAbs) and associated HIV-1 envelope characteristics among seroconverting adults in Botswana.
Moraka NO, Choga WT, Pema MN, Chawawa MK, Gobe I, Mokomane M, Bareng OT, Bhebhe L, Kelentse N, Mulenga G, Pretorius Holme M, Mohammed T, Koofhethile CK, Makhema JM, Shapiro R, Lockman S, Moyo S, Gaseitsiwe S. Moraka NO, et al. Among authors: pema mn. Sci Rep. 2023 Oct 24;13(1):18134. doi: 10.1038/s41598-023-44722-2. Sci Rep. 2023. PMID: 37875518 Free PMC article.
Low prevalence of archived integrase strand transfer inhibitors resistance associated mutations in Botswana before the roll out of dolutegravir based first line antiretroviral therapy.
Maruapula D, Ditshwanelo D, Pema MN, Bareng OT, Choga WT, Moraka NO, Mokgethi PT, Seatla KK, Koofhethile CK, Zuze BJ, Gaolathe T, Pretorius-Holme M, Lebani K, Makhema J, Novitsky V, Shapiro R, Lockman S, Moyo S, Gaseitsiwe S. Maruapula D, et al. Among authors: pema mn. Front Microbiol. 2024 Oct 24;15:1482348. doi: 10.3389/fmicb.2024.1482348. eCollection 2024. Front Microbiol. 2024. PMID: 39512940 Free PMC article.